Tekedia · May 2026
Tekedia Capital announced its investment in Exonic and described the company as building biological foundation models across noisy, unstructured life-science data.
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Exonic (Exonic Biosciences Inc.) is a YC F25 biotechnology research startup building Exonic Studio, a crowdsourced, no-code biological AI platform for precision gene therapy and synthetic enhancer design. Public sources describe it as open-source, lab-validated, and tournament-based, with a small San Francisco team and early-stage funding.
Primary product
Exonic Studio, an AI-driven crowdsourced drug discovery and synthetic biology platform for designing and wet-lab testing DNA sequences and gene-therapy workflows
Founded
2025
Headquarters
San Francisco, California, United States
Team size
1-10 employees
Work style
Flexible
Industry
Biotechnology Research
Sub-industry
AI for precision gene therapy / biological AI
Offices
San Francisco, CA 94114, United States (HQ)
MBC BioLabs, Dogpatch, San Francisco, CA (hiring/lab location)
Business model
Open-source biological AI platform
Crowdsourced drug-discovery tournaments
No-code workflow platform
Wet-lab-validated research collaboration
Funding
Stage
Seed / pre-seed with follow-on venture financing
Total raised
$625K
Latest round
Seed VC-II · May 2026
May 2026 · Tekedia Capital
Oct 2025 · Y Combinator
Sep 2025
People & investors
Work & culture
Research-heavy, open-source, meritocratic, and community-driven; the company emphasizes tournaments, sharing workflows, and wet-lab validation rather than closed-door biopharma development.
Work style
Flexible
Compensation
Public hiring material shows a Founding Scientist (Synthetic Genomics) role at $120K-$180K with 0.50%-2.50% equity; broader compensation policy is not publicly disclosed.
Product & market
Pricing
Core Studio is publicly described as free/open access; tournaments are prize-based, and no public enterprise pricing is disclosed.
Differentiators
- —Open, meritocratic drug-discovery tournaments
- —Free open-source models in Exonic Studio
- —No-code workflow creation and sharing
- —Wet-lab validation of generated DNA
- —Focus on precision gene therapy and synthetic enhancers
- —Contributor upside-sharing language in launch messaging
Technology
Exonic Studio
open-source biological foundation models
proprietary biological models
synthetic enhancer design
wet-lab validation in HepG2, K562, and SK-N-SH assays
crowdsourced tournament system
no-code workflow builder
Customers
Biotech researchers
Synthetic biologists
Drug discovery teams
Academic scientists
Community contributors participating in tournaments
Competitors
Benchling
Recursion
Insilico Medicine
Isomorphic Labs
Xaira Therapeutics
Scale & contact
Estimated revenue
≈$247K–$773K (third-party estimate; midpoint about $423K)
Estimated monthly visits
1.2K
Traffic estimate as of Jul 2026
Latest news
Exonic on LinkedIn · May 2026
Exonic posted a hiring update for a Founding Scientist in San Francisco, reinforcing that the company was actively hiring in May 2026.
Ben Brimacombe on LinkedIn · Dec 2025
Ben Brimacombe said Exonic's game-driven DNA design found new synthetic enhancers in liver cancer, including sequences that outperformed a Nature benchmark in lab tests.
Y Combinator on LinkedIn · Nov 2025
YC introduced Exonic as an internet-native, crowdsourced drug-discovery company and highlighted its no-code biological AI workflows, tournament model, and lab validation of synthetic enhancer designs.
Jobs and careers at Exonic
0 jobs at Exonic
No open positions
Check back later for new openings